Cell Isolation/Cell Separation Market - Global Forecast 2026-2032

The Cell Isolation/Cell Separation Market is projected to reach USD 6.97 Billion in 2026. It is expected to continue growing at a CAGR of 11.39%, reaching USD 13.51 Billion by 2032.

Cell isolation and cell separation have become essential enabling technologies across biomedical research, clinical diagnostics, regenerative medicine, immunology, oncology, and cell therapy manufacturing. The market is shaped by demand for high-purity viable cells, reproducible workflows, and scalable platforms that support downstream applications such as single-cell sequencing, flow cytometry, proteomics, biomarker discovery, and adoptive cell therapy.

Growth is reinforced by the expansion of precision medicine and the increasing use of peripheral blood mononuclear cells, circulating tumor cells, stem cells, T cells, B cells, natural killer cells, and rare cell populations in translational research. Industry adoption is centered on magnetic-activated cell sorting, fluorescence-activated cell sorting, density gradient centrifugation, filtration, microfluidic separation, and automated closed-system technologies that reduce contamination risk, improve sample integrity, and limit operator variability.

Transformative Shifts in the Cell Separation Landscape

The competitive landscape is shifting from manual, open, and labor-intensive protocols toward automated, closed, and digitally controlled cell separation systems. This transition is particularly important for clinical-grade cell processing, where consistency, sterility, traceability, and compliance with good manufacturing practice expectations are critical.

A second major shift is the convergence of cell separation with single-cell analysis and advanced omics. Researchers increasingly require isolation methods that preserve cell viability, phenotype, RNA integrity, and functional characteristics. As a result, technology developers are prioritizing gentle separation chemistries, microfluidic platforms, label-free technologies, and integrated sample-to-answer workflows that support higher reproducibility in research, diagnostics, and therapeutic manufacturing.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is strengthening the cell isolation and cell separation value chain by improving image-based cell recognition, flow cytometry gating, microfluidic device optimization, predictive maintenance, and quality control analytics. In research settings, AI-assisted analysis helps reduce subjectivity in cell population identification and supports faster interpretation of high-dimensional datasets generated through cytometry, microscopy, and single-cell omics.

In manufacturing, AI can support process monitoring by correlating input sample quality, reagent performance, device settings, and final cell yield or purity. The cumulative impact is higher reproducibility, fewer failed runs, and better decision-making in cell therapy and advanced diagnostics workflows, provided that AI models are validated, auditable, and aligned with regulatory expectations for data integrity, explainability, and quality management.

Key Regional Insights Across Major Markets

North America remains a leading region for cell isolation and cell separation because of strong biopharmaceutical research and development, established clinical trial infrastructure, major academic medical centers, and high adoption of advanced cell analysis technologies. The United States drives much of the demand through cancer immunotherapy, stem cell research, and cell therapy manufacturing, while Canada contributes through translational medicine programs, public research networks, and hospital-linked innovation initiatives.

Europe benefits from a mature life sciences ecosystem, strong regulatory oversight, and sustained investment in advanced therapy medicinal products. The European Union’s emphasis on quality, traceability, and harmonized clinical standards supports adoption of closed and automated cell separation platforms, while the United Kingdom, Germany, France, Italy, Spain, and Russia remain important centers for biomedical innovation, immunology research, oncology programs, and clinical translation.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets scale investments in biotechnology, contract research, hospital-based diagnostics, genomics, and regenerative medicine. Latin America is gaining traction through Brazil and Mexico as research capacity, oncology diagnostics, and laboratory modernization improve. The Middle East, led by GCC healthcare transformation programs, is investing in precision medicine, genomics, and tertiary care infrastructure, while Africa shows emerging demand tied to infectious disease research, oncology diagnostics, blood-based testing, and capacity-building initiatives across public health laboratories and academic institutions.

Key Group Insights for Global Cell Separation Demand

ASEAN is becoming more relevant for cell separation as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines strengthen biomedical research networks, clinical laboratory capacity, and regional healthcare modernization programs. Demand is supported by infectious disease research, cancer diagnostics, immunology studies, and growing partnerships that improve access to advanced life science tools.

The GCC is investing in advanced healthcare infrastructure, genomics, oncology, transplantation medicine, and precision medicine, creating demand for high-quality cell isolation systems in hospital laboratories, specialty centers, and research institutions. The European Union remains influential because of its regulatory clarity, cross-border research funding, quality requirements for advanced therapy medicinal products, and leadership in collaborative biomedical innovation.

BRICS countries represent a large and diverse opportunity because Brazil, Russia, India, China, and South Africa combine high disease burden, expanding research capacity, growing clinical trial participation, and policy interest in domestic biomanufacturing. G7 countries continue to set benchmarks in innovation, reimbursement structures, regulatory science, clinical adoption, and high-complexity laboratory workflows, while NATO countries benefit indirectly from investments in biosecurity, public health preparedness, infectious disease surveillance, and resilient life sciences supply chains.

Key Country Insights Shaping Market Adoption

The United States leads demand for cell isolation technologies through extensive biopharmaceutical research and development, National Institutes of Health-funded research, cancer center networks, advanced diagnostics, and commercial cell therapy development. Canada supports adoption through strong academic hospitals, translational research programs, and public-private life sciences initiatives. Mexico is progressing through laboratory modernization, growing clinical diagnostics capacity, and cross-border healthcare and manufacturing linkages, while Brazil anchors Latin America with expanding biotechnology, oncology research, public health laboratories, and academic medical centers.

In Europe, the United Kingdom, Germany, and France are central to advanced therapy research, cell biology, immunology, clinical translation, and regulated bioprocessing. Italy and Spain contribute through hospital-based research, oncology programs, hematology networks, and academic-industry collaboration. Russia maintains scientific capacity in immunology, cell biology, and biomedical research, although procurement, financing, and international collaboration dynamics may be affected by geopolitical constraints.

China is scaling cell therapy, genomics, oncology research, and biomanufacturing capabilities, making it a major demand center for automated cell separation and high-throughput sample preparation. India combines cost-competitive research services, vaccine and biologics expertise, expanding diagnostics, and a growing precision medicine ecosystem. Japan emphasizes high-quality regenerative medicine, aging-related research, and automation, South Korea is advancing cell therapy, bioprocessing, and translational oncology, and Australia remains important for clinical research, immunology, hematology, and translational medicine across hospital and university networks.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that deliver high purity, high viability, closed processing, and compatibility with downstream single-cell analysis, flow cytometry, sequencing, proteomics, and cell therapy manufacturing. Product roadmaps should emphasize automation, sterile consumables, standardized protocols, digital traceability, and validated performance across diverse sample types to meet research and clinical requirements.

Organizations should also develop region-specific commercialization strategies. In mature markets, differentiation should focus on workflow integration, regulatory readiness, service reliability, application support, and evidence generation. In emerging markets, leaders should prioritize training, scalable pricing models, distributor quality, local service capacity, and partnerships with hospitals, academic centers, public health laboratories, and contract research organizations.

Research Methodology

This executive summary is developed using a structured research methodology that synthesizes public regulatory guidance, peer-reviewed scientific literature, clinical trial activity, life sciences industry disclosures, public health data, and healthcare infrastructure indicators. The analysis focuses on verifiable drivers, technology adoption patterns, regional demand signals, and use cases across research, diagnostics, and therapeutic manufacturing.

The methodology applies cross-validation across primary market signals and secondary evidence to reduce bias. Segmentation considers technology type, cell type, application, end user, region, country, and strategic groups such as ASEAN, GCC, European Union, BRICS, G7, and NATO. Insights are framed to support executive decision-making, visibility, and market intelligence use cases without relying on market sizing, market share, or forecasting assumptions.

Conclusion

Cell isolation and cell separation are moving from supportive laboratory techniques to strategic infrastructure for precision medicine, single-cell biology, immuno-oncology, regenerative medicine, and advanced therapies. Demand is strongest where high-quality research ecosystems, clinical translation, diagnostic modernization, and biomanufacturing capabilities intersect.

Future competitiveness will depend on automation, reproducibility, AI-enabled analytics, regulatory alignment, sterility assurance, and global access. Organizations that combine scientific reliability with scalable workflows, validated performance, and regionally tailored execution will be best positioned to create long-term value in the cell separation market.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cell Isolation/Cell Separation Market, by Product

7.1. Introduction
7.2. Consumables
7.2.1. Disposables
7.2.2. Reagents
7.3. Instruments
7.4. Kits
7.5. Software And Services
7.5.1. Data Analysis Software
7.5.2. Maintenance Services

8. Cell Isolation/Cell Separation Market, by Technology

8.1. Introduction
8.2. Centrifugation
8.3. Filtration
8.4. Flow Cytometry
8.4.1. Analytical Cytometry
8.4.2. Sorting Cytometry
8.5. Magnetic Beads
8.5.1. Macro Beads
8.5.2. Nano Beads
8.6. Microfluidics

9. Cell Isolation/Cell Separation Market, by Cell Type

9.1. Introduction
9.2. B Cells
9.3. Cancer Cells
9.4. Dendritic Cells
9.5. Stem Cells
9.6. T Cells

10. Cell Isolation/Cell Separation Market, by Application

10.1. Introduction
10.2. Cell Therapy
10.3. Immunology
10.4. Infectious Diseases
10.5. Oncology
10.6. Prenatal Testing
10.7. Stem Cell Research

11. Cell Isolation/Cell Separation Market, by End User

11.1. Introduction
11.2. Academic And Research Institutes
11.3. Biotech And Pharma Companies
11.4. Contract Research Organizations
11.5. Hospitals And Clinics

12. Cell Isolation/Cell Separation Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Cell Isolation/Cell Separation Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Cell Isolation/Cell Separation Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Akadeum life Sciences
16.2. Alfa Laval AB
16.3. Beckman Coulter, Inc.
16.4. Becton Dickinson and Company
16.5. Bio-Rad Laboratories, Inc.
16.6. Bio-Techne Corporation
16.7. BioLegend, Inc.
16.8. Capricorn Scientific
16.9. CD Bioparticles
16.10. Corning Incorporated
16.11. Cytiva by Global Life Sciences Solutions USA LLC
16.12. F. Hoffmann-La Roche Ltd.
16.13. GE HealthCare Technologies Inc.
16.14. GenScript Biotech Corporation
16.15. IDEX Health & Science LLC
16.16. Invent Biotechnologies, Inc.
16.17. LeanGene
16.18. Merck KGA
16.19. MiCareo Inc.
16.20. Miltenyi Biotec B.V. & Co. KG
16.21. NVIGEN, Inc.
16.22. pluriSelect Life Science UG & Co. KG
16.23. Promega Corporation
16.24. PromoCell GmbH
16.25. Proteintech Group, Inc.
16.26. Sartorius AG
16.27. STEMCELL Technologies Inc.
16.28. Takara Bio Inc.
16.29. Terumo BCT, Inc.
16.30. Thermo Fisher Scientific, Inc.

List of Figures

FIGURE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL DISPOSABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL DISPOSABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL DISPOSABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CENTRIFUGATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CENTRIFUGATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CENTRIFUGATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FILTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FILTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FILTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ANALYTICAL CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ANALYTICAL CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ANALYTICAL CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SORTING CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SORTING CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SORTING CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MAGNETIC BEADS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MAGNETIC BEADS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MAGNETIC BEADS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MACRO BEADS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MACRO BEADS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MACRO BEADS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NANO BEADS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NANO BEADS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NANO BEADS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MICROFLUIDICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MICROFLUIDICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL B CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL B CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL B CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CANCER CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CANCER CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CANCER CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DENDRITIC CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL DENDRITIC CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DENDRITIC CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL T CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL T CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL T CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CELL THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PRENATAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PRENATAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL STEM CELL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 137. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 138. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 139. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 140. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 141. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 142. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 143. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 157. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 158. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 159. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 160. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 161. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 162. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 163. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 168. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 169. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 170. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 171. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 172. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 173. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 174. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 178. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 179. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 180. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 182. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 183. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 184. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 185. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 197. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 198. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 199. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 200. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 201. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 202. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 203. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 204. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 208. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 209. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 210. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 211. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 212. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 213. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 214. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 215. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 217. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 218. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 219. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 220. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 221. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 222. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 223. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 224. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 235. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 237. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 239. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 240. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 241. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 243. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 244. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 245. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. CANADA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 249. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 250. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 251. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 253. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 254. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 255. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. MEXICO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 277. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 278. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 279. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 280. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 281. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 282. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 283. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 284. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 285. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. GERMANY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 289. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 290. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 291. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 292. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 293. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 294. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 295. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. FRANCE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 306. RUSSIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 309. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 310. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 311. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 313. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 314. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 315. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. ITALY CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 319. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 320. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 321. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 322. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 323. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 324. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 325. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 326. SPAIN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 327. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 329. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 330. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 331. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 332. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 333. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2017-2032 (USD MILLION)
TABLE 334. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 335. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 336. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. INDIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. INDIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 339. INDIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 340. INDIA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY

Companies Mentioned

Akadeum life Sciences
Alfa Laval AB
Beckman Coulter, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioLegend, Inc.
Capricorn Scientific
CD Bioparticles
Corning Incorporated
Cytiva by Global Life Sciences Solutions USA LLC
F. Hoffmann-La Roche Ltd.
GE HealthCare Technologies Inc.
GenScript Biotech Corporation
IDEX Health & Science LLC
Invent Biotechnologies, Inc.
LeanGene
Merck KGA
MiCareo Inc.
Miltenyi Biotec B.V. & Co. KG
NVIGEN, Inc.
pluriSelect Life Science UG & Co. KG
Promega Corporation
PromoCell GmbH
Proteintech Group, Inc.
Sartorius AG
STEMCELL Technologies Inc.
Takara Bio Inc.
Terumo BCT, Inc.
Thermo Fisher Scientific, Inc.

Table Information

Report Attribute	Details
No. of Pages	180
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 6.97 Billion
Forecasted Market Value ( USD ) by 2032	$ 13.51 Billion
Compound Annual Growth Rate	11.3%
Regions Covered	Global
No. of Companies Mentioned	31

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Cell Separation Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights Across Major Markets

Key Group Insights for Global Cell Separation Demand

Key Country Insights Shaping Market Adoption

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cell Separation Technologies Market - Global Forecast 2026-2032

Cell Isolation Market Size, Share, Trends and Forecast by Technique, Cell Type, Product, Application, End Use, and Region, 2026-2034

Rare Cell Isolation Market - Global Strategic Business Report

Cell Separation Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Cell Isolation / Cell Separation - Global Strategic Business Report